Literature DB >> 9450139

Retinoic acid modulation of induced basophil differentiation.

B F Leber1, J A Denburg.   

Abstract

Current models of the regulation of hematopoiesis postulate a combination of both factor-directed cell differentiation/survival acting through intracellular signaling pathways, and factor-independent differentiation along intrinsically set, default pathways. Recent reports have indicated that eosinophil/basophil (Eo-Baso) differentiation may represent one default pathway. Because of the strong modulating effect of all trans-retinoic acid (ATRA) on hematopoietic differentiation, we have investigated the role of ATRA in regulating Eo-Baso differentiation from pluripotent progenitors. Our results indicate that ATRA inhibits Eo-Baso maturation at early stages of lineage commitment. Because allergic responses may depend on the continued recruitment and differentiation of such inflammatory mediators, the ability to modulate this pathway may eventually prove to have a therapeutic role in allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9450139     DOI: 10.1111/j.1398-9995.1997.tb02524.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  3 in total

Review 1.  The impact of diet on asthma and allergic diseases.

Authors:  Valerie Julia; Laurence Macia; David Dombrowicz
Journal:  Nat Rev Immunol       Date:  2015-05       Impact factor: 53.106

2.  Localized Th1-, Th2-, T regulatory cell-, and inflammation-associated hepatic and pulmonary immune responses in Ascaris suum-infected swine are increased by retinoic acid.

Authors:  Harry Dawson; Gloria Solano-Aguilar; Madeline Beal; Ethiopia Beshah; Vandana Vangimalla; Eudora Jones; Sebastian Botero; Joseph F Urban
Journal:  Infect Immun       Date:  2009-03-30       Impact factor: 3.441

Review 3.  Nuclear Receptors in Asthma: Empowering Classical Molecules Against a Contemporary Ailment.

Authors:  Drishti Tiwari; Pawan Gupta
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.